The wire › SEC Form 8-K/A
BIOCRYST PHARMACEUTICALS INC BCRX
Filed with the SEC on Aug 4, 2026. Reported event date Jun 25, 2026.
- Business address
- Durham, NC
- State
- North Carolina
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2836)
- SEC CIK
- 882796
- Accession number
- 0001171843-26-005168
Items reported in this filing
- Item 2.05 Costs Associated with Exit or Disposal Activities
The company reported a restructuring: it committed to exit or dispose of part of its business (for example closing some sites, ending a product line or cutting staff) and expects material costs, under Form 8-K Item 2.05. It does not mean the company is closing; healthy, profitable companies file it too, often alongside an earnings release.
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing